These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28039656)

  • 1. Novel and reported pathogenic variants in exon 11 of BRCA2 gene in a cohort of Sri Lankan young breast cancer patients.
    De Silva S; Tennekoon KH; Dissanayake A; De Silva K; Jayasekara L
    Fam Cancer; 2017 Jul; 16(3):329-338. PubMed ID: 28039656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.
    Saxena S; Chakraborty A; Kaushal M; Kotwal S; Bhatanager D; Mohil RS; Chintamani C; Aggarwal AK; Sharma VK; Sharma PC; Lenoir G; Goldgar DE; Szabo CI
    BMC Med Genet; 2006 Oct; 7():75. PubMed ID: 17018160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel sequence variants and common recurrent polymorphisms of BRCA2 in Sri Lankan breast cancer patients and a family with BRCA1 mutations.
    DE Silva S; Tennekoon KH; Karunanayake EH; DE Silva W; Amarasinghe I; Angunawela P
    Exp Ther Med; 2011 Nov; 2(6):1163-1170. PubMed ID: 22977638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of BRCA1and BRCA2 large genomic rearrangements in Sri Lankan familial breast cancer patients and at risk individuals.
    De Silva S; Tennekoon KH; Karunanayake EH; Amarasinghe I; Angunawela P
    BMC Res Notes; 2014 Jun; 7():344. PubMed ID: 24906410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].
    Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3030-4. PubMed ID: 16324400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline variants of uncertain significance, their frequency, and clinico-pathological features in a cohort of Sri Lankan patients with hereditary breast cancer.
    Gunawardena K; Sirisena ND; Anandagoda G; Neththikumara N; Dissanayake VHW
    BMC Res Notes; 2023 Jun; 16(1):95. PubMed ID: 37277882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance.
    Surowy HM; Sutter C; Mittnacht M; Klaes R; Schaefer D; Evers C; Burgemeister AL; Goehringer C; Dikow N; Heil J; Golatta M; Schott S; Schneeweiss A; Bugert P; Sohn C; Bartram CR; Burwinkel B
    Breast Cancer Res Treat; 2014 Jun; 145(2):451-60. PubMed ID: 24728577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
    Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
    PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individuals.
    De Silva W; Karunanayake EH; Tennekoon KH; Allen M; Amarasinghe I; Angunawala P; Ziard MH
    BMC Cancer; 2008 Jul; 8():214. PubMed ID: 18662409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of three alternative transcripts of the BRCA1 gene in patients with breast cancer and a family history of breast and/or ovarian cancer who tested negative for pathogenic mutations.
    Gambino G; Tancredi M; Falaschi E; Aretini P; Caligo MA
    Int J Mol Med; 2015 Apr; 35(4):950-6. PubMed ID: 25683334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically Significant Unclassified Variants in
    Yoon KA; Park B; Lee BI; Yang MJ; Kong SY; Lee ES
    Cancer Res Treat; 2017 Jul; 49(3):627-634. PubMed ID: 27658390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing.
    Kluska A; Balabas A; Paziewska A; Kulecka M; Nowakowska D; Mikula M; Ostrowski J
    BMC Med Genomics; 2015 May; 8():19. PubMed ID: 25948282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of BRCA1 and BRCA2 variants in multi-ethnic Asian cohort from a Malaysian case-control study.
    Lai KN; Ho WK; Kang IN; Kang PC; Phuah SY; Mariapun S; Yip CH; Mohd Taib NA; Teo SH
    BMC Cancer; 2017 Feb; 17(1):149. PubMed ID: 28222693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early-onset breast cancer in Cyprus.
    Loizidou M; Marcou Y; Anastasiadou V; Newbold R; Hadjisavvas A; Kyriacou K
    Clin Genet; 2007 Feb; 71(2):165-70. PubMed ID: 17250666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela.
    Lara K; Consigliere N; Pérez J; Porco A
    Biol Res; 2012; 45(2):117-30. PubMed ID: 23096355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of germline mutations in cancer predisposition genes to tumor etiology in young women diagnosed with invasive breast cancer.
    Rummel SK; Lovejoy L; Shriver CD; Ellsworth RE
    Breast Cancer Res Treat; 2017 Aug; 164(3):593-601. PubMed ID: 28503720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of BRCA1 and BRCA2 variants found in a Norwegian breast or ovarian cancer cohort.
    Jarhelle E; Riise Stensland HM; Mæhle L; Van Ghelue M
    Fam Cancer; 2017 Jan; 16(1):1-16. PubMed ID: 27495310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mis-splicing in breast cancer: identification of pathogenic BRCA2 variants by systematic minigene assays.
    Fraile-Bethencourt E; Valenzuela-Palomo A; Díez-Gómez B; Goina E; Acedo A; Buratti E; Velasco EA
    J Pathol; 2019 Aug; 248(4):409-420. PubMed ID: 30883759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline sequence variants contributing to cancer susceptibility in South African breast cancer patients of African ancestry.
    Eygelaar D; van Rensburg EJ; Joubert F
    Sci Rep; 2022 Jan; 12(1):802. PubMed ID: 35039564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.